InvestorsHub Logo
Followers 17
Posts 581
Boards Moderated 0
Alias Born 05/18/2018

Re: None

Thursday, 08/12/2021 8:01:47 PM

Thursday, August 12, 2021 8:01:47 PM

Post# of 461483
Most important info from call...(imho)...

---------
The Jones Trading analyst asked, regarding the Avatar rett study, do we have an idea when you are having FDA conversation, and if the trial size needs to change to become a pivotal trial, and also some color on the Avatar and Excellence dosing levels.

Dr.Missling: We are in the dialogue right now with the agency and would like to provide update later. Regarding doses we have a dose that is >5mg, but want to keep details blinded, as we do not want inadvertent unblinding of dosing.

---------

Rett adult approval is the critical, first path, to A2-73 commercialization. It sounds like Dr.M is probably discussing U.S. data and pivotal use of upcoming Avatar!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News